These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16306077)

  • 1. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells.
    Kwon M; Ling Y; Maile LA; Badley-Clark J; Clemmons DR
    Endocrinology; 2006 Mar; 147(3):1458-65. PubMed ID: 16306077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor.
    Ling Y; Maile LA; Clemmons DR
    Mol Endocrinol; 2003 Sep; 17(9):1824-33. PubMed ID: 12791772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
    Maile LA; Clemmons DR
    Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.
    Lieskovska J; Ling Y; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2006 Sep; 281(35):25041-53. PubMed ID: 16825188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.
    Radhakrishnan Y; Maile LA; Ling Y; Graves LM; Clemmons DR
    J Biol Chem; 2008 Jun; 283(24):16320-31. PubMed ID: 18420583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.
    Xi G; Shen X; Radhakrishnan Y; Maile L; Clemmons D
    Endocrinology; 2010 Aug; 151(8):3611-23. PubMed ID: 20534722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
    Zhang S; Broxmeyer HE
    Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells.
    Ling Y; Maile LA; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2005 Feb; 280(5):3151-8. PubMed ID: 15546884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
    Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
    Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3',5'-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells.
    Nedachi T; Akahori M; Ariga M; Sakamoto H; Suzuki N; Umesaki K; Hakuno F; Takahashi SI
    Endocrinology; 2000 Jul; 141(7):2429-38. PubMed ID: 10875243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
    Carlberg K; Rohrschneider LR
    J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
    Clemmons DR; Maile LA
    Mol Endocrinol; 2005 Jan; 19(1):1-11. PubMed ID: 15528274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.